Stratec SE (SBS.DE) XETRA
Currency In EUR
- General
- Statistics
- Historical Data
- Profile
- Financials
Stratec SE
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Employees
1462
First IPO Date
June 16, 2000
Key Executives
| Name | Title | Pay | Year Born |
| Marcus Wolfinger | Chairman of Board of Management & Chief Executive Officer | 764,000 | 1967 |
| Georg Bauer | Director for Sales & Member of Management Board | 451,000 | 1973 |
| Claus Vielsack | Director of Product Development & Member of Board of Management | 567,000 | 1967 |
| Hermann Leistner | Founder & Advisor | 0 | 1946 |
| Jan Keppeler | Head of Investor Relations, Sustainability & Corporate Communications | 0 | N/A |
| Tanja Bucherl | Chief Financial Officer & Member of Management Board | 0 | 1988 |
Description
Established in 1979 and headquartered in Birkenfeld, Germany, Stratec SE (previously known as STRATEC Biomedical AG until its name change in December 2018) specializes in the development and manufacturing of cutting-edge automation and instrumentation systems. The company caters to the in-vitro diagnostics and life sciences sectors, operating across Germany, the European Union, and globally. Its business is divided into three primary segments: Instrumentation, Diatron, and Smart Consumables. The Instrumentation segment focuses on designing and fabricating automated analytical systems, along with necessary spare parts and supplies, for customers in clinical diagnostics and biotechnology. The Diatron segment provides a suite of systems, components, disposables, and assays for lower-volume hematology and clinical chemistry applications. Finally, the Smart Consumables segment is dedicated to engineering and producing intelligent consumables for the diagnostics, life sciences, and medical technology industries.
